UnitedHealth Group (NYSE:UNH) Shares Acquired Rep. Marjorie Taylor Greene

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on August 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on August 4th.

Representative Marjorie Taylor Greene also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of AbbVie (NYSE:ABBV) on 8/4/2025.
• Purchased $1,001 – $15,000 in shares of United Parcel Service (NYSE:UPS) on 8/4/2025.
• Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 7/15/2025.
• Purchased $1,001 – $15,000 in shares of Palantir Technologies (NASDAQ:PLTR) on 7/15/2025.
• Purchased $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 6/17/2025.
• Purchased $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 6/17/2025.
• Sold $1,001 – $15,000 in shares of lululemon athletica (NASDAQ:LULU) on 6/17/2025.
• Purchased $1,001 – $15,000 in shares of Netflix (NASDAQ:NFLX) on 6/6/2025.
• Purchased $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 6/6/2025.
• Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 6/6/2025.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $304.02 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a market capitalization of $275.34 billion, a PE ratio of 13.17, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The stock’s 50-day simple moving average is $288.91 and its 200-day simple moving average is $396.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group’s revenue was up 12.9% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Wall Street Analysts Forecast Growth

Several research firms have commented on UNH. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 20th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. TD Securities reaffirmed a “hold” rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $366.52.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its position in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Geode Capital Management LLC boosted its position in UnitedHealth Group by 3.3% during the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock worth $6,624,411,000 after purchasing an additional 675,075 shares in the last quarter. Capital International Investors lifted its position in shares of UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of UnitedHealth Group in the second quarter valued at $3,837,207,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.28% of the stock is owned by corporate insiders.

About Representative Greene

Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia’s 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 14th Congressional District. She declared candidacy for the 2026 election.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.